Table 4.
Significant multivariate predictors of adherence to supervised exercise in the CARE Trial, 2008–2011, Canada
Variable | Standardized beta (β) | p value |
---|---|---|
Location/Center |
0.41 |
< 0.001 |
Endocrine symptoms |
0.14 |
0.009 |
Group assignment |
−0.13 |
0.009 |
Exercise limitations |
−0.13 |
0.009 |
Length of chemotherapy protocol |
−0.12 |
0.015 |
VO2peak, ml/kg/min | 0.12 | 0.017 |